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The anthrax toxin receptors, ANTXR1 and ANTXR2, act as molecular clamps to prevent the protective antigen (PA) toxin
subunit from forming pores until exposure to low pH. PA forms pores at pH ,6.0 or below when it is bound to ANTXR1, but
only at pH ,5.0 or below when it is bound to ANTXR2. Here, structure-based mutagenesis was used to identify non-conserved
ANTXR2 residues responsible for this striking 1.0 pH unit difference in pH threshold. Residues conserved between ANTXR2 and
ANTXR1 that influence the ANTXR2-associated pH threshold of pore formation were also identified. All of these residues
contact either PA domain 2 or the neighboring edge of PA domain 4. These results provide genetic evidence for receptor
release of these regions of PA as being necessary for the protein rearrangements that accompany anthrax toxin pore
formation.
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INTRODUCTION
Anthrax toxin is a major virulence factor of Bacillus anthracis that is
thought to cause many of the symptoms observed in anthrax
disease. The toxin consists of a single receptor-binding subunit,
protective antigen (PA), and two catalytic subunits: lethal factor
(LF), a metalloprotease that cleaves and inactivates MKKs [1–3],
and edema factor (EF), a calmodulin-dependent adenylate cyclase
that converts ATP into cAMP [4,5]. PA binds to either of two host
cell receptors, ANTXR1 (anthrax toxin receptor, ATR/TEM8)
and ANTXR2 (capillary morphogenesis gene 2, CMG2) [6,7].
After binding the cellular receptor, the 83 kD form of PA, (PA83),
is cleaved by cell-surface furin into a 63 kD form, (PA63), which
goes on to heptamerize into a ring, or pre-pore [8]. Alternatively,
cell surface receptors may engage the cleaved PA63, which exists as
monomers or multimers in the blood of infected animals [9,10].
The toxin-receptor complex is internalized by a mechanism
involving LRP6 [11], and trafficked to a low pH endocytic
compartment where acid pH triggers pore formation and trans-
location of the catalytic moieties into the cytoplasm [12–14].
PA is comprised of four protein domains with different
functions: following PA20 removal and PA63 oligomerization,
domain 1 binds EF and/or LF; domain 2 is involved in pore
formation, EF/LF translocation, PA63 oligomerization, and
receptor binding; domain 3 in PA63 oligomerization; and domain
4 in receptor binding [15]. PA binds to a von Willebrand factor A
(vWA) domain that is common to both receptors and most similar
to the inserted (I) domains of a-integrins [16]. Similar to a-
integrin-ligand interactions, a carboxylate side-chain from PA
domain 4 (residue D683) directly coordinates the divalent cation
bound at the receptor metal ion dependent adhesion site (MIDAS)
[17,18]. The co-crystal structure of the ANTXR2 I domain bound
to PA has shown that the contact surface between these two
proteins is much larger (,2000 A ˚ 2) than typical a-integrin-ligand
binding (,1300 A ˚ 2) [17,18]. The extensive contact of ANTXR2
with PA domains 2 and 4 most likely accounts for the very high
affinity of the ANTXR2 I domain-PA interaction (KD=170 pM)
[19]. By contrast, the ANTXR1 I domain-PA interaction exhibits
a much lower binding affinity (KD=130 nM) [20].
In the absence of receptor, PA63 forms pores at neutral pH,
while low pH is required for pore formation when the toxin
subunit is bound to receptor. Thus it has been proposed that each
receptor acts as a molecular clamp to restrict pore formation until
the complex encounters an acidic endosomal compartment where
low pH induces structural changes in the PA heptameric pre-pore
leading to pore formation. In this model, receptor contact with the
base (residues 340–348) of the PA domain 2 membrane insertion
loop (b2- b3; residues 285–340) restrains pore formation until
protonation of PA and/or ANTXR2 residues loosens this inter-
action to allow domain 2 to undergo a large conformational
change and form an extended b-barrel pore [17,18,21,22]. The
pH required for pore formation when PA is bound to ANTXR2
(pH ,5.0) is fully one unit lower than when it is bound to
ANTXR1 (pH ,6.0), suggesting that the receptor might dictate
the subcellular location of pore formation [14,23]. Based upon the
difference in pH threshold for pore formation, ANTXR1 is con-
sidered to be the weaker molecular clamp, being released more
easily from PA than is ANTXR2. Consistent with these pH
requirements, ANTXR2-, but not ANTXR1-, mediated cellular
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which raises endosomal pH [14].
Prior to this report it was not known which receptor deter-
minants are responsible for dictating the receptor-specific pH
thresholds of anthrax toxin pore formation. Here we identify these
determinants of ANTXR2 and show that they are involved with
binding PA domain 2 and the neighboring edge of PA domain 4.
METHODS
DNA constructs, cell transfections and protein
production
QuikChange mutagenesis (Stratagene) was performed on
ANTXR2-EGFP (CMG2
489-EGFP) [7] or ANTXR1-EGFP
(ATR/TEM8 sv2-EGFP) [6] plasmids with oligonucleotide
primers described in Table S1. For transient receptor expression,
,5610
6 CHO-R1.1 cells were transfected with 1 or 3 mg plasmid
DNA ANTXR1- or ANTXR2-EGFP and 5 or 3 mg pBSII KS(-)
carrier DNA using Lipofectamine2000 (Invitrogen). All constructs
were confirmed by DNA sequencing. WT PA protein was isolated
from the periplasm of E. coli [24], and purified as previously
described [25]. LFN-DTA (the N-terminal, PA-binding domain of
LF fused to the catalytic A chain of diphtheria toxin, which kills
cells when internalized) was produced as previously described [26].
Cell intoxication assays
At 24 hours post-transfection, triplicate samples of ,7610
5 cells
were plated in 12-well culture dishes and pre-incubated for 1 hour
with 30 mM NH4Cl, or media only. Then cells were incubated for
6 hours with 5610
28 M PA and 10
210 ML F N-DTA, or LFN-
DTA alone, at which point the media was changed and all samples
were incubated with 30 mM ammonium chloride changed every
6 hours for ,18 hours. Cells were analyzed by flow cytometry and
the percentage of live, EGFP-positive cells in the presence of PA
and LFN-DTA was divided by that in the LFN-DTA alone sample
(no toxin killing) to determine the relative EGFP cell viability. WT
ANXTR2-expressing cells are normally susceptible to an NH4Cl
block to intoxication, while ANTXR1-expressing cells are resistant
[14]. Cytosolic EGFP-expressing cells were used as a negative
control for intoxication (data not shown).
PA pore formation on cell surfaces
At 48 hours post-transfection, ,2610
6 cells were pre-incubated in
supplemented F12 media with dGAB cocktail [50 mM 2-deoxy-
glucose (Sigma), 10 mM sodium azide (Sigma), 200 nM bafilo-
mycin A1 (Alexis Biochemicals)] for 45 minutes at 37uC. Cells
were then bound with 10
28 MP A 63 (List Labs) in the presence of
dGAB for 2 hours at 4uC. Pore formation was induced by
incubation for 10 minutes at 37uC with PBS buffered with Tris
pH 6.8, Tris pH 6.5, MES pH 6.0, MES pH 5.6, MES pH 5.4
and Sodium Acetate pH 5.0 or alternatively MES pH 6.0, MES
pH 5.8, MES pH 5.6, MES pH 5.4, Sodium Acetate pH 5.2, and
Sodium Acetate pH 5.0 respectively (final pH). Samples were
analyzed as previously described [14].
RESULTS
Homolog-scanning mutagenesis of ANTXR2
We reasoned that non-conserved amino acid residues located at
the PA-binding interface were likely to be responsible, at least in
part, for the distinct receptor-specific pH thresholds of anthrax
toxin pore formation. There are eight such residues in ANTXR2
(A56, N57, Q88, S113, V115, D152, G153, and L154), which
correspond to Leu, His, Arg, Leu, Gly, His, Glu, and Asp,
respectively, in ANTXR1 [17,18] (Fig. 1A). To test their involve-
ment, each ANTXR2 residue was independently replaced by the
corresponding ANTXR1 residue in the context of an ANTXR2-
EGFP fusion protein [7]. The altered receptors were expressed in
transiently-transfected CHO-R1.1 cells, which lack PA receptors
[6]. The pH threshold of PA pore formation was then measured in
each case using a previously described assay [14] (Fig. 1B).
Among the mutations in PA domain 2 contact residues, the
D152H mutation had almost no effect on the pH threshold of pore
formation (data not shown). By contrast, the G153E and L154D
amino acid substitutions weakened the ANTXR2 molecular
clamp, allowing PA pore formation at a pH value that was 0.6
units higher than that seen with wild-type ANTXR2 (Fig. 1B).
Indeed, when these two mutations were combined (construct
ANTXR2 153–154), ANTXR2 was fully converted into a receptor
with the pore-inducing properties of ANTXR1 (Fig. 1B). Consis-
tently, the G153E, L154D and 153–154 amino acid substitutions
rendered cellular intoxication via ANTXR2, which is normally
sensitive to inhibition by NH4Cl treatment, resistant to that
treatment (Fig. 1C).
Among the mutations tested in PA-domain 4 contact residues all
had almost no effect on the pH of pore formation (data not shown)
with the exception of the Q88R mutation that weakened the
molecular clamp, allowing PA pore formation at pH 5.4 (Fig. 1B).
These data indicated that residues G153 and L154, located in the
b4-a4 loop of the receptor I domain, which contacts PA domain 2,
and residue Q88 which contacts PA domain 4, are major
determinants of the lower pH threshold requirement associated
with ANTXR2.
Homolog-scanning mutagenesis of ANTXR1
To determine their sufficiency for the low pH threshold of pore
formation associated with ANTXR2, residues G153, L154, and
Q88 were introduced at the corresponding positions of ANTXR1.
The ANTXR1 155–156 protein, with ANTXR2 residues G153
and L154 replacing the corresponding residues E155 and D156 of
ANTXR1, displayed only a modest (0.4 pH unit) shift in threshold
of PA pore formation (Fig. 2A and Fig. 2B). Consistently, intoxica-
tion via this mutant receptor was still inhibitable by NH4Cl
(Fig. 2C). Therefore, these two residues conferred only partial
ANTXR2-like properties on the ANTXR1 receptor.
To test whether additional b4-a4 loop residues are required to
convert ANTXR1 more fully into an ANTXR2-like receptor,
ANTXR1 residues 154–159 were replaced with the corresponding
amino acids of ANTXR2 (Fig. 2A). The ANTXR1 154–159
protein exhibited an additional 0.2 pH unit shift in the pH
threshold of PA pore formation beyond that observed with
ANTXR1 155–156 (Fig. 2B). Furthermore, in contrast to
ANTXR1 155–156, PA pore formation associated with the
ANTXR1 154–159 protein was sensitive to ammonium chloride
inhibition (Fig. 2C). These data show that additional residues
located in the b4-a4 loop of ANTXR2 can further convert
ANTXR1 into a receptor, which acts more like ANTXR2.
To test the additional requirement for ANTXR2 residue Q88,
this residue was substituted in the ANTXR1 154–159 protein,
generating the ANTXR1 R88Q/154–159 protein. This additional
change fully converted ANTXR1 154–159 into an ANTXR2-like
receptor that restricted pore formation to pH 5.0 or below
(Fig. 2B). These results provide an independent line of evidence
that b4-a4 loop region residues including G153 and L154, as well
as Q88, of ANTXR2 are largely responsible for dictating the 1.0
pH unit difference in the receptor-specific pH threshold of toxin
pore formation.
Anthrax Toxin Receptor Clamp
PLoS ONE | www.plosone.org 2 March 2007 | Issue 3 | e329Figure 1. Mutagenesis of ANTXR2. (A) Ribbon model of ANTXR2-PA binding interface (UCSF Chimera; PDB# IT6B) [17]. PA domain 2 (PA-D2) and PA
domain 4 (PA-D4) are colored light and dark blue, respectively, and the ANTXR2 I domain is colored dark green. The Mn
2+ cation bound by the
ANTXR2 MIDAS is shown in magenta. ANTXR2 residues that are not conserved in ANTXR1 and are involved in PA-D2 and PA-D4 contacts are depicted
in orange and red stick representation, respectively. (B) Cells transiently expressing ANTXR2-EGFP or mutant ANTXR2-EGFP receptors treated with
dGAB for 45 mins at 37uC were incubated with PA63 at 4uC in the presence of dGAB to prevent PA internalization, and pore formation was induced by
exposure to low pH buffers before lysing cells. PA pores, which correspond an SDS-resistant high molecular weight species, were detected by SDS-
PAGE and immunoblotting with an anti-PA serum followed by an HRP-conjugated secondary antibody. The high molecular weight, SDS-resistant
species on the blot representing PA pore are shown. These data are representative examples of at least three similarly performed independent
experiments. (C) Triplicate samples of cells expressing WT ANTXR2-EGFP, and ANTXR2-EGFP with G153E, L154D, and 153–154 mutations were treated
with PA and LFN-DTA in the presence or absence of 30 mM NH4Cl and assayed for cell viability as described in materials and methods.
doi:10.1371/journal.pone.0000329.g001
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PLoS ONE | www.plosone.org 3 March 2007 | Issue 3 | e329Figure 2. Mutagenesis of ANTXR1. (A) Structural diagram of the unique ANTXR2 residues involved in PA domain 2 contact. Residues 152–154 are
depicted in orange stick representation with a mesh space-fill overlay, and those residues (155–157) that may affect display of the upstream contact
residues are depicted in yellow sticks. The numbered residues of ANTXR2 are shown in white type. PA is depicted in space-fill representation, where C
is grey, N is blue and O is red and the numbered residues are shown in black type. Below is an alignment of the primary sequence for this region in
ANTXR2 and ANTXR1. The residues depicted in orange and yellow above are underlined; non-conserved changes in ANTXR1 are highlighted in red;
and the ANTXR2 G153 and L154 residues shown to be important in Fig. 1 are boxed. (B) PA pore formation was assayed at different pH values on the
surfaces of cells transiently expressing ANTXR1-EGFP and mutant ANTXR1-EGFP receptors, as described in Fig. 1B. These data are representative
examples of at least three similarly performed independent experiments. (C) Triplicate samples of cells were assayed for intoxication with PA and LFN-
DTA in the presence or absence of 30 mM NH4Cl and analyzed for cell viability as described in Fig. 1C.
doi:10.1371/journal.pone.0000329.g002
Anthrax Toxin Receptor Clamp
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residues
At the PA binding interface, ANTXR2 amino acid residues K51,
Y119, H121, E122 and Y158 are absolutely conserved with
ANTXR1, and residues S87, R111 and E117 are residues are
highly similar (Thr, Lys and Asp, respectively, in ANTXR1)
[17,18] (Fig. 3A). We reasoned that some of these residues are
likely to constitute a conserved core of the molecular clamp
mechanism that is shared by both anthrax toxin receptors. To test
their involvement in the context of ANTXR2, each of these
residues was independently changed to an Ala, and in some cases
also to other amino acid side chains.
Among the PA domain 2-contact residues, the most important
was Y119: changing this residue either to an Ala or Phe signifi-
cantly weakened the molecular clamp allowing some toxin pore
formation at pH 5.6–6.0 (Fig. 3B). Also, mutant receptors bearing
either H121A, H121N, H121E, E122Q, E122R, Y158A, or
Y158F amino acid substitutions displayed a 0.2–0.4 pH unit shift
in this threshold (Fig. 3B). Among the PA domain 4-contact
residues, changing residue E117, either to an Ala, or to the
structurally-related Gln side chain, led to a weaker molecular
clamp that allowed PA pore formation at pH 5.2–5.4 (Fig. 3B).
Taken together these results indicate that the conserved residues
E117, Y119, H121, E122, and Y158, which contact PA domain 2
and the neighboring edge of domain 4, influence the low pH
threshold of ANTXR2-associated anthrax toxin pore formation.
DISCUSSION
In this report, receptor determinants that influence the strength of
the ANTXR2 clamp which acts to restrict PA pore formation at
neutral pH have been defined. Residues G153 and L154, located
on the b4-a4 loop of the receptor I domain which interacts with
the flexible 340–380 loop of PA domain 2 [17,18] were shown to
be the major determinants underlying the more acidic pH
requirement for PA pore formation when the toxin is bound to
ANTXR2. Substituting both of these residues in ANTXR2 for the
corresponding ANTXR1 amino acids gave rise to a much weaker
molecular clamp with the pH threshold properties of ANTXR1.
Moreover, the ANTXR2 residues G153 and L154 strengthened
the ANTXR1 molecular clamp when they were introduced
together, especially in combination with residue Q88 and
additional b4-a4 loop residues (ANTXR2 residues 152–157), at
corresponding positions of the ANTXR1 receptor.
Residue G153 permits a tight turn in the b4-a4 loop and L154
participates in hydrophobic contacts with the side-chains of PA
Figure 3. Mutagenesis of conserved receptor residues. (A) Ribbon model of the ANTXR2-PA interaction as described in the Fig. 1A legend. ANTXR2
residues that are conserved in ANTXR1 and are involved in PA-D2 and PA-D4 contact are depicted in orange and red stick representation,
respectively. The PA residues E654 (dark blue) and R344 (light blue) that form salt-bridges with receptor residues K51 and E122, respectively, are also
shown in stick representation. The position on the polypeptide backbone of PA residues G342 and D683 is also shown. (B) PA pore formation was
assayed at different pH values on the surfaces of cells transiently expressing ANTXR2-EGFP and mutant ANTXR2-EGFP receptors, as described in
Fig. 1B. The shaded region of the bar indicates the pH range where complete pore formation was observed, while the striped region of the bar
indicates partial pore formation (as seen at pH 5.4 for Q88R and pH 5.6 for G153E in Fig. 1B). The results shown represent pooled data obtained from
at least 3 independent experiments except in those cases where no effect (N.E.) was observed. In those cases, the data were collected from at least
two independent experiments. PA bound to wild-type ANTXR2 formed pores between 5.0–5.2 (grey shaded area); receptors with mutations in this
same pH range were determined to have no effect (N.E.).
doi:10.1371/journal.pone.0000329.g003
Anthrax Toxin Receptor Clamp
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the b4-a4 loop of ANTXR2 contains a Pro residue (P155) that
induces a backbone kink and is aliphatic and solvent-exposed,
along with a neighboring Ser residue (S156). However, the
corresponding residues of ANTXR1 are very hydrophobic (F158
and F159, respectively) (Fig. 2A). Thus, it seems likely that this
region of ANTXR1 will adopt a very different conformation from
that of ANTXR2, one that affects the surface presentation of PA
domain 2-contact residues, potentially weakening the toxin
interaction. Indeed, the contacts between the ANTXR1 I domain
and PA domain 2 have yet to be characterized structurally.
Among the conserved receptor residues, the key regulator of
acid pH-dependent pore formation was Y119 of ANTXR2, which
occupies a planar position between domains 2 and 4 of PA (Fig. 4A)
and appears to make hydrophobic and H-bond interactions with
both domains. In particular, the hydroxyl moiety of this residue is
critical since replacement by Phe also gave rise to a dramatic 0.6–
0.8 unit shift in the pH threshold of toxin pore formation (Fig. 4A).
Figure 4. Receptor residues involved in molecular clamp function. (A) Structural diagram of the contribution of individual residues to the receptor
molecular clamp (from the monomeric ANTXR2-PA structure solved at 2.5 A ˚ resolution; PDB# IT6B)[17]. Molecular clamp residues from panel A are
colored black if mutation of the residue caused a 0.4–0.6 pH unit shift in pore formation, or grey if the mutation caused a,0.4 pH unit shift in pore
formation. (B) Left, Two ANTXR2 I domains bound to a PA63 dimer from the heptameric PA-ANTXR2 structure (solved at 4.3 A ˚ resolution; PBD
#ITZN)[18]. PA domains 2 and 4 are depicted in light and dark blue respectively, with the membrane insertion loop (residues 285–340) from PA
domain 2 colored red. Right, One ANTXR2 I domain-PA monomer complex. Structural diagram of the contribution of individual residues to the
receptor molecular clamp. Molecular clamp residues from panel A are colored black if mutation of the residue caused a 0.4–0.6 pH unit shift in pore
formation, or grey if the mutation caused a,0.4 pH unit shift in pore formation.
doi:10.1371/journal.pone.0000329.g004
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make stabilizing H-bonds with the backbone of PA residue A341
and/or the side-chain of PA residue R659 in the PA prepore-
receptor complex (Fig. 4A). Leppla and collaborators have also
recently shown that the ANTXR2 Y119H mutation has a major
effect upon the pH threshold of PA pore formation [27].
Substituting other conserved residues E117, H121, E122, and
Y158 each gave rise to similar 0.2–0.4 unit changes in the pH
threshold of toxin pore formation (Fig. 4A). E117 is H-bonded to
the PA D683 backbone (Fig. 3A). The imidazole ring of H121 does
not make any H-bonds with PA in the co-crystal structure, but this
residue is in close proximity to ANTXR2 E122, the PA G342
backbone and PA R344 side-chain (Fig. 3A). A salt bridge between
ANTXR2 residue E122 and PA residue R344 was recently
implicated in strengthening the ANTXR2 receptor clamp [27].
The hydroxyl moiety of ANTXR2 Y158 appears to be important
since a Phe substitution at this position led to a modest decrease in
clamp strength. However, it is unknown how this hydroxyl
participates because Y158 does not make H-bonds with the
monomeric or prepore forms of PA [17,18].
It remains to be determined if the residues implicated in this
study affect the affinity of PA-ANTXR2 binding at neutral pH; the
long half-life of the complex (15 hours) [19] precluded the use of
moderate throughput analysis of all the mutants. Indeed, even
SPR analysis is not sensitive enough to accurately measure the
apparent Kd of the toxin-wild-type receptor complex and a more
sensitive FRET-based assay involving the use of AF488 (donor
fluorophore)-labeled PA and AF546 (acceptor fluorophore)-labeled
ANTXR2 I domain had to be used in that study. Consequently,
previous measurements obtained by binding PA to cell surfaces for
1 hour at 4uC [27,28] likely reflect only association rate differences
between different mutant ANTXR2 proteins. Since these experi-
ments are not performed under equilibrium conditions, they also
likely underestimate the actual PA-binding affinities of wild-type
and mutant forms of ANTXR2.
The ANTXR2 residues that form the functional core of the
receptor clamp, as well as those that dictate the receptor-specific
pH thresholds of pore formation, map to the region that contacts
PA domain 2 and the neighboring edge of PA domain 4 (Fig. 4A).
These data therefore provide genetic evidence that receptor
release of these two PA regions is likely necessary to allow the
unfurling of the 285–340 region of PA domain 2 involved in pore
formation (Fig. 4B). Our results also illuminate the genetic basis for
the previous observation that there was a one unit difference in the
pH threshold at which ANTXR2 and ANTXR1 allowed toxin
pore formation, and support a model where toxin pore formation
may be occurring in different endosomal compartments depending
on the receptor bound [14]. Previously it was noted that the pH
profile of anthrax toxin pore formation was consistent with the
titration of histidines and that there are several histidines (H299,
H304, H310, and H336), located in the 285–340 region of PA
which forms the membrane-spanning pore [17,18]. Moreover, it
was suggested that ANTXR2 residue H121 might be a key
component of this triggering mechanism since this residue is
located at the PA domain 2 binding interface and is conserved in
ANTXR1 [17,18]. However, the current study excludes a major
role for ANTXR2 residue H121 since its substitution by other
amino acids had only a modest effect on the pH of pore formation.
The precise molecular changes in PA-receptor complexes, which
accompany anthrax toxin pore formation in response to a low pH
stimulus, remain to be determined and are under investigation.
SUPPORTING INFORMATION
Table S1 Mutagenesis Primers
Found at: doi:10.1371/journal.pone.0000329.s001 (0.07 MB
DOC)
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